Clinical Trials Directory

Trials / Completed

CompletedNCT02603796

3D Imaging of Neonatal Faces

3D Imaging of Neonatal Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Sharp HealthCare · Academic / Other
Sex
All
Age
24 Weeks – 42 Weeks
Healthy volunteers
Not accepted

Summary

Facial scans of newborns will be performed before and after implementation of respiratory support devices such as nasal CPAP. 3D scanned images will be processed by Fisher \& Paykel Healthcare Limited. Images will be analyzed for changes or distortion in nasal structure.

Detailed description

Any newborns admitted to the neonatal intensive care unit at Sharp Mary Birch Hospital for Women and Newborns between 24-42 weeks CGA with parental informed consent are eligible. 3D scanned image will be obtained prior to implementation of nasal support devices and after nasal support devices. Fisher \& Paykel Healthcare Limited will analyze the 3D images and observations will be made for changes in nasal structure or distortion.

Conditions

Interventions

TypeNameDescription
OTHER3D Scan of nares3D scan of subjects nose prior to implementation of ncpap and upon discontinuation of ncpap.

Timeline

Start date
2015-10-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-11-13
Last updated
2016-07-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02603796. Inclusion in this directory is not an endorsement.

3D Imaging of Neonatal Faces (NCT02603796) · Clinical Trials Directory